EUVIMEDEUVIMED entdecken
Multizentrische Studie

Long‐term multicentre analysis of robot‐assisted radical cystectomy for non‐muscle‐invasive bladder cancer

Neeraja Tillu iD, Reuben Ben-David iD, Viktor Skokic, Jordan M Rich iD, Kaushik P Kolanukuduru iD, Linda Dey, Juhana Rautiola iD, Johan Björklund iD, Mohammed Almoflihi, Ahmed Eraky iD, Gus Miranda, Giovanni Cacciamani und 4 weitere

BJU International · 2025-09 · 136 (3) · 545-552

DOI: 10.1111/bju.16686 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift BJU International, online erschienen am 20.02.2025. Verfasst von Neeraja Tillu und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, Icahn School of Medicine at Mount Sinai, New York, New York, USA. Hauptthemen laut MEDLINE: Urinary Bladder Neoplasms, Cystectomy, Robotic Surgical Procedures. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 30 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

To evaluate the 12‐year survival outcomes of patients with non‐muscle‐invasive bladder cancer (NMIBC) who underwent robot‐assisted radical cystectomy (RARC) with intracorporeal urinary diversion (ICUD), focusing on those upstaged to ≥pT2 or with node‐positive disease. Materials and Methods A multicentre, prospectively maintained database (2004–2022) was reviewed to identify patients who had undergone RARC. Univariable and multivariable models were used to assess upstaging (≥pT2, ≥pN1), and Kaplan–Meier curves were used to predict cancer‐specific survival (CSS) and overall survival (OS).

Results

Among 355 patients with NMIBC (295 men, 60 women), 12.68% had pT2, 8.2% had pT3, 4.2% had pT4, 5.4% had pN1, and 2.8% had pN2 disease. Age ≥ 83 years (odds ratio [OR] 19.7), presence of carcinoma in situ (CIS), in combination with Ta/ T1 bladder cancer (OR 2.7), squamous cell carcinoma (OR 6.6), and variant histology (OR 6.2), predicted upstaging. A body mass index ≥28 kg/m 2 (OR 0.4) and Tis alone (OR 0.1) reduced upstaging. The OS rate for the entire cohort was 93% at 1 year, 87% at 5 years and 49% at 12 years. The CSS rate was 97% at 1 year, 83% at 5 years and 76% at 12 years. At 12 years, OS was better in the non‐upstaged cohort (52%, 95% confidence interval [CI] 37%–74%) vs the upstaged cohort (39%, 95% CI 26%–57%). CSS was higher in the non‐upstaged cohort (79%, 95% CI 71%–88%; P < 0.001) vs the upstaged cohort (68%, 95% CI 56%–82%; P < 0.001).

Conclusion

This study provides the longest follow‐up data on RARC in NMIBC. The presence of CIS, variant histology, and pT1 on transurethral resection of the bladder tumour were predictors of upstaging, which correlated with higher recurrence and worse survival. RARC with ICUD is a minimally invasive option for NMIBC patients who need to undergo early cystectomy, offering comparable long‐term outcomes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Urinary Bladder NeoplasmsCystectomyRobotic Surgical ProceduresHumansMaleFemaleAgedAged, 80 and overMiddle AgedNeoplasm InvasivenessUrinary DiversionNon-Muscle Invasive Bladder Neoplasms

Stichwörter der Autor:innen

NMIBCbladder cancercystectomyileal conduitintracorporealneobladdernon‐muscle invasiverobot‐assisted surgeryurinary diversion

Autor:innen und Institutionen

  • Department of Urology, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
  • Department of Pelvic Cancer, Karolinska University Hospital, Stockholm, Sweden.
  • Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden.
  • Department of Urology, Keck School of Medicine, University of Southern California, Los Angeles, California, USA.

ORCID-Profile: Neeraja Tillu, Reuben Ben-David, Jordan M Rich, Kaushik P Kolanukuduru, Juhana Rautiola, Johan Björklund, Ahmed Eraky, Mihir Desai

Zitieren

APA

Tillu, N., Ben-David, R., Skokic, V., Rich, J. M., Kolanukuduru, K. P., Dey, L., Rautiola, J., Björklund, J., Almoflihi, M., Eraky, A., Miranda, G., Cacciamani, G., Desai, M., Mehrazin, R., Sfakianos, J. P., & Wiklund, P. (2025). Long‐term multicentre analysis of robot‐assisted radical cystectomy for non‐muscle‐invasive bladder cancer. BJU International, 136(3), 545-552. https://doi.org/10.1111/bju.16686

Vancouver

Tillu N, Ben-David R, Skokic V, Rich JM, Kolanukuduru KP, Dey L, et al. Long‐term multicentre analysis of robot‐assisted radical cystectomy for non‐muscle‐invasive bladder cancer. BJU International. 2025;136(3):545-552. doi:10.1111/bju.16686

BibTeX
@article{Tillu2025,
  author = {Tillu, Neeraja and Ben-David, Reuben and Skokic, Viktor and Rich, Jordan M and Kolanukuduru, Kaushik P and Dey, Linda and Rautiola, Juhana and Björklund, Johan and Almoflihi, Mohammed and Eraky, Ahmed and Miranda, Gus and Cacciamani, Giovanni and Desai, Mihir and Mehrazin, Reza and Sfakianos, John P and Wiklund, Peter},
  title = {Long‐term multicentre analysis of robot‐assisted radical cystectomy for non‐muscle‐invasive bladder cancer},
  journal = {BJU International},
  year = {2025},
  volume = {136},
  number = {3},
  pages = {545--552},
  doi = {10.1111/bju.16686}
}
Kostenlos starten →